1
|
Chen JY, Li TT, Hao YQ, Tang HP. [Pulmonary cryptococcosis coexisting with lung cancer confirmed by pathological examinations: report of 3 cases and literature review]. Zhonghua Jie He He Hu Xi Za Zhi 2022; 45:1009-1014. [PMID: 36207957 DOI: 10.3760/cma.j.cn112147-20220312-00197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
Objective: To describe the clinical characteristics of pulmonary cryptococcosis(PC)coexisting with lung cancer. Methods: We reported 3 cases of PC coexisting with lung cancer confirmed by pathology in Qingdao Municipal Hospital from January 2017 to December 2021.We reviewed the literature with"pulmonary cryptococcosis" and "lung cancer" as the keywords to search Wanfang database, China HowNet and PubMed database. Results: The patients consisted of 2 males and 1 female. Two patients were diagnosed with nodular type of PC and one with diffuse mixed type of PC. One patient had underlying cardiovascular diseases and the other two had no medical history. The clinical manifestations varied including fever, cough, sputum, and no specific symptoms. All the patients received surgery and postoperative medical therapy, and all 3 patients were pathologically confirmed with adenocarcinoma. A total of 18 cases were retrieved from related literatures. To our knowledge, one of our cases was the first one with diffuse mixed type of PC coexisting with lung cancer. Conclusions: Coexistence of pulmonary cryptococcosis and lung cancer is rare and the clinical symptoms are nonspecific. When PC coexists with lung cancer, it is extremely easy to be misdiagnosed. Therefore, PC should be considered in the differential diagnosis of pulmonary nodules and multiple imaging changes.
Collapse
Affiliation(s)
- J Y Chen
- Department of Respiratory Medicine, Qingdao Municipal Hospital, Qingdao 266071, China
| | - T T Li
- Department of Respiratory Medicine, Qingdao Municipal Hospital, Qingdao 266071, China
| | - Y Q Hao
- Department of Respiratory Medicine, Qingdao Municipal Hospital, Qingdao 266071, China
| | - H P Tang
- Department of Respiratory Medicine, Qingdao Municipal Hospital, Qingdao 266071, China
| |
Collapse
|
2
|
Yang CC, Ma J, Li T, Luo W, Mu Y, Tang HP, Lan XJ. Structural Organization and Functional Activity of the Orthologous TaGLW7 Genes in Bread Wheat (Triticum aestivum L.). RUSS J GENET+ 2019. [DOI: 10.1134/s1022795419050168] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
3
|
Lin JT, Xing B, Tang HP, Yang L, Yuan YD, Gu YH, Chen P, Liu XJ, Zhang J, Liu HG, Wang CZ, Zhou W, Sun DJ, Chen YQ, Chen ZC, Huang M, Lin QC, Hu CP, Yang XH, Huo JM, Ye XW, Zhou X, Jiang P, Zhang W, Huang YJ, Dai LM, Liu RY, Cai SX, Xu JY, Zhou JY. [Seasonal distribution of patient hospitalization due to asthma exacerbation in 7 geographic areas in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2019; 39:1477-1481. [PMID: 30462957 DOI: 10.3760/cma.j.issn.0254-6450.2018.11.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To understand the seasonal distribution of patient hospitalization due to asthma exacerbation in 7 geographic areas in China. Methods: This was a retrospective study which involved patients hospitalized for asthma exacerbation in 29 hospitals throughout 7 geographic areas in the mainland of China (northeast, north, central, east, south, northwest and southwest). The numbers of asthmatic patients and total inpatients of the respiratory department of each hospital were recorded. The monthly ratio of asthmatic patients to the total inpatients in every area was calculated and compared. Results: During the study period, 6 480 patients were admitted for asthma exacerbation, accounting for 3.14% of all the 206 135 patients admitted to the respiratory departments in the 29 hospitals. The ratio of asthmatic patients to total inpatients in the northeast area (5.61%) was highest, and the ratio in east area was lowest (1.97%). Statistical analysis showed that the difference among different areas was significant (P<0.000 1). In most areas, both the number and proportion of hospitalized asthmatic patients peaked in spring (February-April) and autumn (September-October). In the northeast area, east area and south area, the peaks in spring were more obvious, while in the north area and southwest area, the peaks in autumn were more obvious. In the northwest area the peaks occurred in winter (December-January) and summer (June-August), respectively. The differences in hospitalization due to asthma among different months were significant in the northeast, north, and southwest areas (P<0.005). Conclusion: The number of patients hospitalized for asthma exacerbation fluctuated with season in different areas in China. In most areas, more asthmatic patients were admitted to hospitals in spring and autumn.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | - B Xing
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | - H P Tang
- Department of Respiration, Qingdao Municipal Hospital, Qingdao 266000, China
| | - L Yang
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China
| | - Y D Yuan
- Department of Respiration, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - Y H Gu
- Department of Respiration, Qinghai People's Hospital, Xining 810007, China
| | - P Chen
- Department of Respiratory Diseases, The General Hospital of Shenyang Military, Shenyang 110016, China
| | - X J Liu
- Department of Respiration, The First Affiliated Hospital of Lanzhou University, Lanzhou 730000, China
| | - J Zhang
- Department of Pulmonary and Critical Care Medicine, The Second Hospital of Jilin University, Changchun 130041, China
| | - H G Liu
- Department of Respiration, Tongji Hospital, Wuhan 430030, China
| | - C Z Wang
- Department of Respiration, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
| | - W Zhou
- Department of Respiration, General Hospital of Ningxia Medical University, Yinchuan 750004, China
| | - D J Sun
- Department of Pulmonary and Critical Care Medicine, Inner Mongolia People's Hospital, Hohhot 010017, China
| | - Y Q Chen
- Department of Respiration, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
| | - Z C Chen
- Department of Respiration, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - M Huang
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China
| | - Q C Lin
- Department of Respiration, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
| | - C P Hu
- Department of Respiration, Xiangya Hospital, Changsha 410008, China
| | - X H Yang
- Department of Pulmonary and Critical Care Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China
| | - J M Huo
- Department of Respiration, The First Affiliated Hospital of Harbin Medical University, Harbin 150081, China
| | - X W Ye
- Department of Respiration, Guizhou Provicial People's Hospital, Guiyang 550002, China
| | - X Zhou
- Department of Respiration, Shanghai Center Hospital, Shanghai 200025, China
| | - P Jiang
- Department of Respiration, Tianjin First Center Hospital, Tianjin 300192, China
| | - W Zhang
- Department of Respiration, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - Y J Huang
- Department of Respiration, Hainan Provincial People's Hospital, Haikou 570311, China
| | - L M Dai
- Department of Respiration, Kunming General Hospital of the People's Liberation Army, Kunming 650032, China
| | - R Y Liu
- Department of Respiration, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
| | - S X Cai
- Department of Respiration, Nanfang Hospital, Guangzhou 510515, China
| | - J Y Xu
- Department of Respiration, Shanxi Dayi Hospital, Taiyuan 030032, China
| | - J Y Zhou
- Department of Respiration, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310003, China
| |
Collapse
|
4
|
Lin JT, Xing B, Tang HP, Yang L, Yuan YD, Gu YH, Chen P, Liu XJ, Zhang J, Liu HG, Wang CZ, Zhou W, Sun DJ, Chen YQ, Chen ZC, Huang M, Lin QC, Hu CP, Yang XH, Huo JM, Ye XW, Zhou X, Jiang P, Zhang W, Huang YJ, Dai LM, Liu RY, Cai SX, Xu JY, Zhou JY. [Seasonal characteristics of patients hospitalized for asthma exacerbation in China]. Zhonghua Yi Xue Za Zhi 2019; 97:2324-2328. [PMID: 28822447 DOI: 10.3760/cma.j.issn.0376-2491.2017.30.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the seasonal characteristics of patients hospitalized for asthma exacerbation in China. Methods: This was a retrospective study which involved patients hospitalized for asthma exacerbation in 29 hospitals throughout mainland China during 2013-2014. The number of patients hospitalized for asthma exacerbation in each hospital was calculated, as well as the ratio of asthmatic patients to all the hospitalized patients. The analysis by month was conducted. The number and ratio of asthmatic patients in the northern and southern cities were calculated respectively. Results: During the study period, there were 6 480 patients hospitalized for asthma exacerbation, accounting for 3.14% (6 480/206 135) of all the hospitalized patients of the respiratory department in 29 hospitals. The analysis by month showed that the ratio of patients hospitalized for asthma exacerbation was highest in March (3.49%), then declined from April to June, then rose again from July, reaching a second peak at September (3.28%), and then declined again from October to December. The ratio of asthmatic patients in every month was higher in northern cities than in southern cities. Conclusions: The ratio of patients hospitalized for asthma exacerbation in China fluctuates with the changes of seasons, and March and September are the two peak months. Northern cities have a higher ratio of asthmatic patients than southern cities.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Lin JT, Wang WQ, Zhou X, Wang CZ, Huang M, Cai SX, Chen P, Lin QC, Zhou JY, Gu YH, Yuan YD, Sun DJ, Yang XH, Yang L, Huo JM, Chen ZC, Jiang P, Zhang J, Ye XW, Liu HG, Tang HP, Liu RY, Liu CT, Zhang W, Hu CP, Chen YQ, Liu XJ, Dai LM, Zhou W, Huang YJ, Xu JY. [Warning symptoms of asthma attack and asthma self-management: a national asthma control survey from China]. Zhonghua Yi Xue Za Zhi 2019; 97:2329-2332. [PMID: 28822448 DOI: 10.3760/cma.j.issn.0376-2491.2017.30.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate warning symptoms of asthma attack and evaluate asthma self-management status of asthma patients in urban China. Methods: A multi-center, cross-sectional, questionnaire-based survey was carried out from 30 general hospitals dispersed in 30 provinces of mainland China (except for Tibet) during Oct 2015 to May 2016. Information of frequency and warning symptoms of asthma attack, the time from warning symptoms to asthma attack, the impact of asthma attack and asthma self-management were collected from asthma patients of outpatient department. Results: Altogether 3 875 asthmatic outpatients were recruited. 78.1% (3 026/3 875) of the patients reported restriction of exercise and daily activities during asthma exacerbation. 82.5% (3 160/3 829) of the patients had warning symptoms before asthma attack, the most common warning symptoms were cough, chest tightness and shortness of breath. The median time from warning symptoms to asthma attack was 2 h, the mean time was 90 h. Only 4.4% (167/3 829) of the patients had definite confidence to control asthma when symptoms deteriorated. 76.7% (2 937/3 828) of the patients used medications to control asthma when asthma symptoms deteriorated. Medication choice: inhaled corticosteroid (ICS) + formoterol 45.8% (1 776/3 875), short-acting beta-agonist (SABA) 23.9% (927/3 875). Conclusions: Most asthma patients have warning symptoms before asthma attack, the most common symptoms are cough, chest tightness and shortness of breath. The proportion of patients conducting effective asthma self-management remains low.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Lin JT, Wang WQ, Zhou X, Wang CZ, Huang M, Cai SX, Chen P, Lin QC, Zhou JY, Gu YH, Yuan YD, Sun DJ, Yang XH, Yang L, Huo JM, Chen ZC, Jiang P, Zhang J, Ye XW, Liu HG, Tang HP, Liu RY, Liu CT, Zhang W, Hu CP, Chen YQ, Liu XJ, Dai LM, Zhou W, Huang YJ, Xu JY. [The level of asthma control in China from a national asthma control survey]. Zhonghua Jie He He Hu Xi Za Zhi 2019; 40:494-498. [PMID: 28728272 DOI: 10.3760/cma.j.issn.1001-0939.2017.07.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To assess the overall asthma control level in urban China. Methods: A multi-center, cross-sectional, questionnaire-based survey was carried out in 30 provinces in China (except Tibet). Asthmatic outpatients who met the inclusion criteria were recruited consecutively from 30 sub-centers from October 2015 to May 2016. Data of demographic characteristics, asthma control, asthma management, asthma exacerbations and self-management, and disease perception were collected by face-to-face interviews. Results: Totally 3 875 asthmatic outpatients were recruited. Asthma control level was assessed according to GINA 2015. The prevalence of asthma control was 28.5%(1 099/3 854). Among 10 cities, which were also involved in the asthma control survey in 2008, the level of asthma control improved from 28.7% in 2008 to 39.2%(533/1 361) in 2016. The rate of hospitalizations due to asthma exacerbations was 26.4%(1 017/3 858) and the rate of emergency visits was 22.4%(864/3 858). Among adult patients, 18.4%(568/3 092) of them had been absent from work while 63.6%(63/99) adolescent patients had been absent from school because of asthma attacks in the previous year. Conclusion: Although the level of asthma control in China is still far from ideal at present, the status has been improved in some cities. Poorly controlled asthma resulted in increase of hospitalizations, emergency department visits and work/school absences.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Lin JT, Xing B, Tang HP, Yang L, Yuan YD, Gu YH, Chen P, Liu XJ, Zhang J, Liu HG, Wang CZ, Zhou W, Sun DJ, Chen YQ, Chen ZC, Huang M, Lin QC, Hu CP, Yang XH, Huo JM, Ye XW, Zhou X, Jiang P, Zhang W, Huang YJ, Dai LM, Liu RY, Cai SX, Xu JY, Zhou JY. [A multi-center retrospective study of clinical characteristics and hospitalization costs of patients hospitalized for asthma exacerbation in China during 2013-2014]. Zhonghua Jie He He Hu Xi Za Zhi 2019; 40:830-834. [PMID: 29320830 DOI: 10.3760/cma.j.issn.1001-0939.2017.11.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the characteristics of patients hospitalized for asthma exacerbation in 29 teaching hospitals in China and to evaluate the hospitalization costs of these patients. Methods: This was a retrospective study and involved patients hospitalized for asthma exacerbation in 29 hospitals throughout China during 2013-2014. Information about the demographic features, conditions before the admission, the outcome, the complications, and the costs was collected using the pre-designed case report form. The influencing factors of the hospitalization costs were analyzed. Results: 3 240 asthmatic patients (1 369 males and 1 871 females) were included and data were analyzed. There were 41.5% (1 346/3 240) patients who had a history of previous hospitalization or emergency department visits during the last year. Only 28.0% (907/3 240) patients had used asthma-controlling medications regularly before the admission. Seventy-three(2.3%) patients were admitted to ICU and used mechanical ventilation. Mortality among these patients hospitalized for asthma exacerbation was 0.25% (8/3 240). The median hospitalization costs was 9 045(6 431, 13 035) RMB. The costs of medications, examinations and treatment accounted for 52.1%, 27.6%, and 9.6% respectively. The costs of asthma medications accounted for only 22.7% of the total medication costs, while the costs of antibiotics accounted for 44.0%. The patients who were admitted to ICU, used mechanical ventilation, complicated with pneumonia, or had a history of hospitalization or emergency department visits during the last year due to asthma exacerbations tended to cost more. Conclusion: In this study, we demonstrated that only a minority of the patients had used asthma controllers regularly before the admissions with exacerbations. The in-hospital mortality of asthma patients in this study was much lower than that reported in other countries. The average cost of hospitalization was much higher than the yearly cost of maintenance therapy. Medication was the predominant component of the total hospitalization costs, and the costs of antibiotics made up the major part of the total medication costs.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Xing B, Lin JT, Tang HP, Yang L, Yuan YD, Gu YH, Chen P, Liu XJ, Zhang J, Liu HG, Wang CZ, Zhou W, Sun DJ, Chen YQ, Chen ZC, Huang M, Lin QC, Hu CP, Yang XH, Huo JM, Ye XW, Zhou X, Jiang P, Zhang W, Huang YJ, Dai LM, Liu RY, Cai SX, Xu JY, Zhou JY. [A retrospective study of the treatment of patients hospitalized for asthma exacerbation in China]. Zhonghua Yi Xue Za Zhi 2018. [PMID: 29534393 DOI: 10.3760/cma.j.issn.0376-2491.2018.08.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the treatment of patients hospitalized for asthma exacerbation in China. Methods: This was a retrospective study and involved patients hospitalized for asthma exacerbation in 29 hospitals throughout China during Jan 2013 to Dec 2014. Information of the demographic features, the severity of the exacerbation, the medicine prescribed during the hospitalization and the use of mechanical ventilation were collected and analyzed. Results: During the study period, there were 3 240 patients hospitalized for asthma exacerbation, and 1 369(42.3%) of them were males 1 871(57.7%)were females. Patients of mild, moderate, severe, and life-threatening exacerbation counted for 41.7%, 37.8%, 19.2% and 1.0%, respectively of the total patients. Of all the patients, 72.6% used bronchodilators by nebulizer, 70.8% used inhaled corticosteroids by nebulizer, 60.5% used intravenous corticosteroids, 17.3% used oral corticosteroids, and 80.5% used antibiotics. The percentages of patients using systemic corticosteroids and antibiotics were higher in patients with more severe exacerbation. In patients with mild exacerbation, there were 74.9% and 52.2% who used antibiotics and systemic corticosteroids, respectively. A total of 73 patients (2.3%) used mechanical ventilation, and 62 of them used noninvasive ventilation, 16 used invasive ventilation, and 5 used both. Conclusions: Nebulizer therapy has been accepted as the main administration route of medicine in the treatment of asthma exacerbation. A large amount of patients used antibiotics and systemic corticosteroids during hospitalization, indicating there may be some overuse of these medicines.
Collapse
Affiliation(s)
- B Xing
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Wang WQ, Lin JT, Zhou X, Wang CZ, Huang M, Cai SX, Chen P, Lin QC, Zhou JY, Gu YH, Yuan YD, Sun DJ, Yang XH, Yang L, Huo JM, Chen ZC, Jiang P, Zhang J, Ye XW, Liu HG, Tang HP, Liu RY, Liu CT, Zhang W, Hu CP, Chen YQ, Liu XJ, Dai LM, Zhou W, Huang YJ, Xu JY. [Evaluation of asthma disease perception from China national asthma control survey]. Zhonghua Yi Xue Za Zhi 2018; 98:467-471. [PMID: 29429262 DOI: 10.3760/cma.j.issn.0376-2491.2018.06.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: In order to evaluate disease perception of asthma patients in urban China and provide evidence for further specific patient education. Methods: A multi-center, cross-sectional, questionnaire-based survey was carried out in 30 general hospitals dispersed in 30 provinces of mainland China (except for Tibet) during Oct 2015 to May 2016. Information of disease perception [Question 1: the disease nature of asthma; Question 2: medication choice of first-line in chronic asthma; Question 3: the occasion of using short-acting aerosols of receptor agonists; Question 4: perception of asthma treatment goal; Question 5: reason for not using peak flow meter (PFM)] were collected from asthma patients of outpatient department. These results were compared with the same type of survey results from 2007-2008. Results: Altogether 3 875 asthmatic outpatients were recruited. 69.0% (2 660/3 857) of the patients had right perception on the disease nature of asthma, 60.2% (2 321/3 857) of the patients considered inhaled corticosteroids (ICS)/inhaled corticosteroids plus long-acting beta2-agonists (ICS+ LABA) as daily-used first-line medication for chronic asthma. 85.7% (3 277/3 823) of the patients had right perception on the condition of using short-acting beta2-agonists (SABA). 75.4% (2 761/3 661) of the patients had right perception on asthma treatment goal. Only 10.1% (388/3 837) of the patients used PFM. Of the reasons for not using PFM, 65.2% (2 518/3 860) of the patients chose doctors never introduced. Among the 10 cities, which were also involved in the asthma control survey in 2007-2008, 71.1% (968/1 361) of the patients had right perception on the disease nature of asthma, 61.6% (839/1 362) of the patients considered ICS/ICS+ LABA as daily-used first-line medication for chronic asthma. 88.7% (1 207/1 361) of the patients had right perception on the condition of using SABA. 74.5% (1 013/1 360) of the patients had right perception on asthma treatment goal. 17.9% (244/1 360) of the patients used PFM. Of the reasons for not using PFM, 76.2% (931/1 221) of the patients chose doctors never introduced. Compared to the survey conducted in 2007-2008, the perception on disease nature and medication choice as daily-used first-line medication for chronic asthma significantly improved, the perception on occasion of using SABA and asthma treatment goal was comparable, while the rate of PFM usage showed no significant improvement. In reasons of not using PFM, doctors never introduced ranked the first. Conclusions: Compared to the similar survey conducted in 2007-2008, the overall status of disease perception of asthma patients has been improved in urban China, while the rate of PFM usage showed no significant improvement. Asthma education on asthma and asthma self-management should be further pushed forward.
Collapse
Affiliation(s)
- W Q Wang
- Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Lin JT, Xing B, Tang HP, Yang L, Yuan YD, Gu YH, Chen P, Liu XJ, Zhang J, Liu HG, Wang CZ, Zhou W, Sun DJ, Chen YQ, Chen ZC, Huang M, Lin QC, Hu CP, Yang XH, Huo JM, Ye XW, Zhou X, Jiang P, Zhang W, Huang YJ, Dai LM, Liu RY, Cai SX, Xu JY, Zhou JY. [A retrospective study of the mortality and death-related risk factors of patients hospitalized for asthma exacerbation in Chinese urban areas]. Zhonghua Yi Xue Za Zhi 2018; 98:2760-2763. [PMID: 30220175 DOI: 10.3760/cma.j.issn.0376-2491.2018.34.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the mortality and death-related risk factors of patients hospitalized for asthma exacerbation in Chinese urban areas. Methods: A retrospective study was carried out in 29 hospitals of 29 provinces throughout mainland China. Patients hospitalized for asthma exacerbation during 2013-2014 in each hospital were included. For each patient, information about demography, admission time, comorbidities, severity of diseases, intense care unit (ICU) admission, use of mechanical ventilation and the outcome was obtained. The mortality of patients hospitalized for asthma exacerbation was calculated, and the basic information and causes of death of the patients who died were summarized. The death-related risk factors and numbers of comorbidities were compared between the patients who survived and those who died during hospitalization. Results: A total of 3 240 patients (median age 57.0) were included and among them 8 patients (median age 68.5) died. The mortality of patients hospitalized for asthma exacerbation was 0.25%. All the patients who died were admitted during the winter and spring. One patient died of acute myocardial infarction, one of cardiac shock, one of tension pneumothorax, one of sudden death, one of respiratory failure and three of unknown causes. The average number of comorbidities of patients who died was 1.10, larger than that of patients who survived (0.83) (P>0.05). More patients had diabetes, coronary artery diseases and hypertension as comorbidities in the patients who died (2/8) than those who survived[7.6% (246/3 232), 7.6% (246/3 232), 22.6% (731/3 232), respectively](all P>0.05). Conclusions: The in-hospital mortality of patients hospitalized for asthma exacerbation of China in this study is low. The patients who died are much older, and with more comorbidities, and a higher percentage of comorbidities such as diabetes, coronary artery diseases, and hypertension.
Collapse
Affiliation(s)
- J T Lin
- Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, National Clinical Research Centre for Respiratory Medicine, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Nong Y, Lin JT, Wang WQ, Zhou X, Wang CZ, Huang M, Cai SX, Chen P, Lin QC, Zhou JY, Gu YH, Yuan YD, Sun DJ, Yang XH, Yang L, Huo JM, Chen ZC, Jiang P, Zhang J, Ye XW, Liu HG, Tang HP, Liu RY, Liu CT, Zhang W, Hu CP, Chen YQ, Liu XJ, Dai LM, Zhou W, Huang YJ, Xu JY. [A multi-center study for the association between the perception and control of disease among asthmatic patients in Chinese urban areas]. Zhonghua Yi Xue Za Zhi 2018; 97:1425-1429. [PMID: 28535631 DOI: 10.3760/cma.j.issn.0376-2491.2017.18.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the current perception of disease among asthmatic patients in Chinese urban areas, and to address its association with asthma control. Methods: This was a nationwide, multi-center, cross-sectional study covering 30 third-level, grade A hospitals in 30 provinces, municipalities and autonomous regions (not including Tibet) across Chinese mainland. The survey was carried out from October 2015 to May 2016. Asthmatic outpatients were selected to receive face-to-face questionnaire survey on asthma control including Asthma Control Test (ACT) score, classification of asthma control level[according to the Global Initiative for Asthma (GINA) 2015 classification system, as assessed by the physician completing the survey], perception of asthma (including question 1: nature of asthma as a disease; question 2: selection of first-line therapeutic agents to be regularly used daily for asthma; question 3: appropriate timing of the use of short-acting aerosols of β(2) receptor agonists; and question 4: therapeutic goals for asthma). Results: A total of 3 875 asthmatic outpatients were included; among them, 69.0% (2 660/3 857) were aware that asthma is "an airway inflammatory disorder resulting from the combined effects of heredity and environment" ; 60.2% (2 321/3 857) considered "inhaled glucocorticoids or their compound preparations" to be the first-line therapeutic agents to be regularly used daily for patients with persistent chronic asthma; 85.7% (3 277/3 823) considered it appropriate to use short-acting aerosols of β(2) receptor agonists "as needed in the event of disease aggravation or acute exacerbation" ; and 75.4% (2 761/3 661) were aware that asthma "can be adequately or completely controlled in the long term" . The ACT score[20 (16, 23) vs 19 (16, 22) points; Z=-3.928, P<0.001]and asthma control rate (29.92% vs 25.31%; χ(2)=8.616, P=0.003) were significantly higher, and the rate of uncontrolled asthma (19.92% vs 23.48%; χ(2)=6.267, P=0.012) was significantly lower among the 2 660 (69.0%) patients correctly answering question 1 than among the 1 197 (31.0%) patients giving incorrect answer. The ACT score[21 (17, 23) vs 19 (15, 22) points; Z=-9.190, P<0.001] and asthma control rate (32.66% vs 22.20%; χ(2)=49.614, P<0.001) were significantly higher, and the rate of uncontrolled asthma (18.40% vs 25.00%; χ(2)=24.267, P<0.001) was significantly lower among the 2 321 (60.2%) patient correctly answering question 2 than among the 1 536 (39.8%) patients giving incorrect answer. Conclusions: Compared to previous surveys, there has been improved perception of disease among asthmatic patients in Chinese urban areas. Correct perception of disease is favorable for improving asthma control level.
Collapse
Affiliation(s)
- Y Nong
- Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Gui N, Xu W, Myers DE, Shukla R, Tang HP, Qian M. The effect of ordered and partially ordered surface topography on bone cell responses: a review. Biomater Sci 2018; 6:250-264. [DOI: 10.1039/c7bm01016h] [Citation(s) in RCA: 65] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Current understanding of the role of ordered and partially ordered surface topography in bone cell responses for bone implant design.
Collapse
Affiliation(s)
- N. Gui
- Centre for Additive Manufacturing
- School of Engineering
- RMIT University
- Melbourne
- Australia
| | - W. Xu
- Department of Engineering
- Macquarie University
- Sydney
- Australia
| | - D. E. Myers
- Australian Institute for Musculoskeletal Science
- Victoria University and University of Melbourne
- Australia
- College of Health and Biomedicine
- Victoria University
| | - R. Shukla
- Nanobiotechnology Research Laboratory and Centre for Advanced Materials & Industrial Chemistry
- School of Science
- RMIT University
- Melbourne
- Australia
| | - H. P. Tang
- State Key Laboratory of Porous Metal Materials
- Northwest Institute for Nonferrous Metal Research
- and Xi'an Sailong Metal Materials Co. Ltd
- Xi'an 710016
- China
| | - M. Qian
- Centre for Additive Manufacturing
- School of Engineering
- RMIT University
- Melbourne
- Australia
| |
Collapse
|
13
|
Mohamed SS, Khalid SA, Ward SA, Wan TS, Tang HP, Zheng M, Haynes RK, Edwards G. Simultaneous determination of artemether and its major metabolite dihydroartemisinin in plasma by gas chromatography-mass spectrometry-selected ion monitoring. J Chromatogr B Biomed Sci Appl 1999; 731:251-60. [PMID: 10510778 DOI: 10.1016/s0378-4347(99)00232-7] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
A sensitive, selective, and reproducible GC-MS-SIM method was developed for determination of artemether (ARM) and dihydroartemisinin (DHA) in plasma using artemisinin (ART) as internal standard. Solid phase extraction was performed using C18 Bond Elut cartridges. The analysis was carried out using a HP-5MS 5% phenylmethylsiloxane capillary column. The recoveries of ARM, DHA and ART were 94.9 +/- 1.6%, 92.2 +/- 4.1% and 81.3 +/- 1.2%, respectively. The limit of quantification in plasma was 5 ng/ml (C.V. < or = 17.4% for ARM and 15.2% for DHA). Calibration curves were linear with R2 > or = 0.988. Within day coefficients of variation were 3-10.4% for ARM and 7.7-14.5% for DHA. Between day coefficients of variations were 6.5-15.4% and 7.6-14.1% for ARM and DHA. The method is currently being used for pharmacokinetic studies. Preliminary data on pharmacokinetics showed Cmax of 245.2 and 35.6 ng/ml reached at 2 and 3 h and AUC0-8 h of 2463.6 and 111.8 ngh/ml for ARM and DHA, respectively.
Collapse
Affiliation(s)
- S S Mohamed
- Department of Pharmaceutics, Faculty of Pharmacy, University of Khartoum, Sudan
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Abstract
Cardiac troponin I (cTnI) is an essential element in activation of myofilaments by Ca2+ binding to cardiac troponin C (cTnC). Yet, its role in transduction of the Ca2+ binding signal to cardiac troponin T (cTnT) and tropomyosin-actin remain poorly understood. We have recently discovered that regions of cTnI C-terminal to a previously defined inhibitory peptide are essential for full inhibitory activity and Ca(2+)-sensitivity of cardiac myofilaments (Rarick et al., 1997). However, apart from its role in structural binding to cTnC, there is little knowledge concerning the role of the N-terminus of cTnI in the activation and regulation of cardiac myofilaments. To address this question, we generated wild-type mouse cardiac TnI (WT-cTnI; 211 residues) and two N-terminal deletion mutants of mouse cTnI, cTnI54-211 (missing 53 residues), and cTnI80-211 (missing 79 residues). The cTnI54-211 mutant retained the ability to bind to cTnT, but lost the ability to bind to cTnC, whereas the cTnI80-211 mutant lost the ability to bind to cTnT, but bound weakly to cTnC. Both mutants bound to F-actin. In the absence of Ca2+, cTnI54-211 was able to inhibit the unregulated MgATPase activity of myofibrils lacking endogenous cTnI-cTnC to the same extent as WT-cTnI, whereas cTnI80-211 had some impairment of its inhibitory capability. Reconstitution with cTnI54-211/cTnC complex did not restore Ca(2+)-activation of myofibrillar MgATPase activity at all, however, the cTnI80-211/cTnC complex restored Ca(2+)-activation to nearly 50% of that obtained with WT-cTnI/cTnC. These data provide the first evidence of a significant function of a cTnT-binding domain on cTnI. They also indicate that the structural cTnC binding site on cTnI is required for Ca(2+)-dependent activation of cardiac myofilaments, and that cTnT binding to the N-terminus of cTnI is a negative regulator of activation.
Collapse
Affiliation(s)
- H M Rarick
- Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago 60612-7342, USA
| | | | | | | | | |
Collapse
|
15
|
Abstract
An immunoconjugate was constructed from a monoclonal antibody recognizing human T-lymphoblastoid cells and a membrane-lytic cytotoxin purified from the venom of the Thailand cobra. Activities of this novel immunoconjugate were compared using human and murine T-lymphocyte cell lines. The ability of the conjugate to inhibit human T-cell proliferation, as measured by incorporation of [3H]thymidine, was three to four times higher than its ability to inhibit proliferation of mouse L1210 cells. The immunoconjugate EC50 for human CEM cells was equivalent to 0.1 nmoles per 2 x 10(5) target cells. Immunoconjugate selectivity paralleled the monoclonal antibody's binding characteristics. Preincubation with free antibody blocked the effect of the conjugate, but only upon the human target cells. This study supports the feasibility of directing a toxic moiety to the surface of a cancer cell to accomplish cell destruction without requiring prior toxin internalization and uncoupling from its antibody carrier.
Collapse
Affiliation(s)
- C L Hinman
- Department of Medicinal and Biological Chemistry, The University of Toledo, OH 43606, USA.
| | | |
Collapse
|
16
|
Zepter K, Häffner A, Soohoo LF, De Luca D, Tang HP, Fisher P, Chavinson J, Elmets CA. Induction of biologically active IL-1 beta-converting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli. The Journal of Immunology 1997. [DOI: 10.4049/jimmunol.159.12.6203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Abstract
IL-1beta, a major mediator of inflammatory and immunologic skin disease, undergoes post-translational site-specific cleavage by a novel cysteine protease termed IL-1beta-converting enzyme (ICE). Although in human skin keratinocytes produce significant amounts of the 31-kDa IL-1beta precursor protein, they fail under nonpathologic conditions to convert it to the 17.5-kDa bioactive form. In this study, we examined whether haptens and inflammatory agents might serve as stimuli for ICE activity in human keratinocytes, and, if so, whether ICE activity might precipitate enzymatic processing of IL-1beta to its 17.5-kDa form. Baseline levels of ICE mRNA were detected in keratinocyte cultures devoid of Langerhans cells and were up-regulated by nontoxic concentrations of the reactive hapten urushiol and by the irritant chemicals sodium lauryl sulfate and PMA. Although untreated keratinocytes expressed the 31-kDa form of the protein, 17.5-kDa IL-1beta was easily detected in keratinocytes and keratinocyte supernatants treated with either urushiol or the irritant chemicals. Enzymatic conversion from the 31-kDa to the 17.5-kDa form of IL-1beta was blocked by addition of a highly specific aldehyde inhibitor that contained a tetrapeptide recognition sequence specific for ICE, but not by an aldehyde inhibitor of a related ICE-like cysteine protease. Induction of IL-1beta-converting enzyme by immunologic and inflammatory stimuli may be one of the key regulatory elements in the pathogenesis of allergic and irritant contact hypersensitivity.
Collapse
Affiliation(s)
- K Zepter
- Skin Diseases Research Center, Department of Dermatology, Case Western Reserve University, Cleveland, OH 44106, USA
| | - A Häffner
- Skin Diseases Research Center, Department of Dermatology, Case Western Reserve University, Cleveland, OH 44106, USA
| | - L F Soohoo
- Skin Diseases Research Center, Department of Dermatology, Case Western Reserve University, Cleveland, OH 44106, USA
| | - D De Luca
- Skin Diseases Research Center, Department of Dermatology, Case Western Reserve University, Cleveland, OH 44106, USA
| | - H P Tang
- Skin Diseases Research Center, Department of Dermatology, Case Western Reserve University, Cleveland, OH 44106, USA
| | - P Fisher
- Skin Diseases Research Center, Department of Dermatology, Case Western Reserve University, Cleveland, OH 44106, USA
| | - J Chavinson
- Skin Diseases Research Center, Department of Dermatology, Case Western Reserve University, Cleveland, OH 44106, USA
| | - C A Elmets
- Skin Diseases Research Center, Department of Dermatology, Case Western Reserve University, Cleveland, OH 44106, USA
| |
Collapse
|
17
|
Zepter K, Häffner A, Soohoo LF, De Luca D, Tang HP, Fisher P, Chavinson J, Elmets CA. Induction of biologically active IL-1 beta-converting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli. J Immunol 1997; 159:6203-8. [PMID: 9550423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
IL-1beta, a major mediator of inflammatory and immunologic skin disease, undergoes post-translational site-specific cleavage by a novel cysteine protease termed IL-1beta-converting enzyme (ICE). Although in human skin keratinocytes produce significant amounts of the 31-kDa IL-1beta precursor protein, they fail under nonpathologic conditions to convert it to the 17.5-kDa bioactive form. In this study, we examined whether haptens and inflammatory agents might serve as stimuli for ICE activity in human keratinocytes, and, if so, whether ICE activity might precipitate enzymatic processing of IL-1beta to its 17.5-kDa form. Baseline levels of ICE mRNA were detected in keratinocyte cultures devoid of Langerhans cells and were up-regulated by nontoxic concentrations of the reactive hapten urushiol and by the irritant chemicals sodium lauryl sulfate and PMA. Although untreated keratinocytes expressed the 31-kDa form of the protein, 17.5-kDa IL-1beta was easily detected in keratinocytes and keratinocyte supernatants treated with either urushiol or the irritant chemicals. Enzymatic conversion from the 31-kDa to the 17.5-kDa form of IL-1beta was blocked by addition of a highly specific aldehyde inhibitor that contained a tetrapeptide recognition sequence specific for ICE, but not by an aldehyde inhibitor of a related ICE-like cysteine protease. Induction of IL-1beta-converting enzyme by immunologic and inflammatory stimuli may be one of the key regulatory elements in the pathogenesis of allergic and irritant contact hypersensitivity.
Collapse
Affiliation(s)
- K Zepter
- Skin Diseases Research Center, Department of Dermatology, Case Western Reserve University, Cleveland, OH 44106, USA
| | | | | | | | | | | | | | | |
Collapse
|
18
|
Anderson C, Hrabovsky S, McKinley Y, Tubesing K, Tang HP, Dunbar R, Mukhtar H, Elmets CA. Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression. Photochem Photobiol 1997; 65:895-901. [PMID: 9155263 DOI: 10.1111/j.1751-1097.1997.tb01940.x] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
The phthalocyanines are promising second-generation photosensitizers that are being evaluated for the photodynamic therapy (PDT) of malignant tumors. In vivo studies with the silicon phthalocyanine Pc 4 have shown that it is highly effective at causing regression of RIF-1 tumors in C3H/HeN mice in PDT protocols. Because cutaneous photosensitivity is the major complication of photosensitizers used for PDT, experiments were performed to evaluate the effect of inhibitors of the inflammatory response (cyproheptadine, dexamethasone, pentoxifylline, and tumor necrosis factor alpha [TNF-alpha] antibodies) on Pc 4-induced cutaneous photosensitivity and tumor regression. The C3H/HeN mice were injected with either Pc 4 or Photofrin and were exposed to 86 J/cm2 of filtered radiation emitted from a solar simulator. Animals were irradiated at 1, 3, 7, 10, 14 and 28 days postinjection. Cutaneous photosensitivity was assessed using the murine ear-swelling response. Cyproheptadine, dexamethasone, pentoxifylline and TNF-alpha antibodies were administered prior to illumination to assess their ability to block Pc 4-induced cutaneous photosensitivity and to evaluate whether such treatment adversely influenced Pc 4 PDT-induced tumor regression. Compared to Photofrin, Pc 4 produced cutaneous photosensitivity that was transient, resolving within 24 h, and that could be elicited for only 10 days after administration. In contrast, Photofrin caused photosensitivity that required 4 days to resolve and could be elicited for at least 1 month after it was administered. The Pc 4-induced cutaneous photosensitivity could be blocked by corticosteroids and an inhibitor of vasoactive amines (cyproheptadine). The TNF-alpha gene transcription was found to increase in keratinocytes following treatment with Pc 4 and light. The anti-TNF-alpha antibodies and pentoxifylline, an inhibitor of cytokine transcription, also prevented cutaneous photosensitivity, implicating TNF-alpha in the pathogenesis of Pc 4-induced cutaneous photosensitivity. None of these agents had any effect on Pc 4 PDT-induced tumor regression. Cyproheptadine, dexamethasone, pentoxifylline and TNF-alpha antibodies may be valuable pharmacologic agents in the management of cutaneous photosensitivity associated with PDT without altering the efficacy of this new therapeutic modality. The findings suggest that it should be possible to devise PDT protocols that block cutaneous photosensitivity without impairing the anti-tumor response to the agents.
Collapse
Affiliation(s)
- C Anderson
- Department of Dermatology, Case Western Reserve University, Cleveland, OH, USA
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Cheng GL, Pan DD, Qu ZY, Lin B, Yang ZX, Fang GR, Gong XS, Tang HP. Digital replantation. A ten-year retrospective study. Chin Med J (Engl) 1991; 104:96-102. [PMID: 1874019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Eight hundred and two digits (592 complete amputation and 210 incomplete amputations) of 549 patients were replanted. The male to female ratio was 3:1 and the age range 1-63 years. 728 digits survived and 74 digits failed. The overall survival rate was 90.8%. Special varieties of complicated amputation were encountered in this series: (1) distal segment replantation, 139 digits, 131 digits (94%) survived; (2) digital replantation of children, 45 cases, 78 digits, average age 3.8 years, the youngest being 1 year old, 68 digits survived (88.7%); (3) rotational avulsion amputation of thumb, 26 digits, 23 digits (88.4%) survived; (4) bilateral digit amputation, 8 cases, 44 digits amputated, 38 digits replanted, including 9 digits of a ten-digit guillotined case. All the digits were salvaged. We conclude that thorough debridement, meticulous anastomosis of blood vessels and timely management of vascular crisis are keys to high survival rate, while judicious selection of indication, proper internal fixation of bone, anastomosis of as many blood vessels as possible, attentive repair of nerves and tendons, sound rehabilitation program are important measures in improving postoperative function.
Collapse
Affiliation(s)
- G L Cheng
- 401st Hospital & Hand Surgery Center, PLA, Qingdao
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Hinman CL, Jiang XL, Tang HP. Selective cytolysis by a protein toxin as a consequence of direct interaction with the lymphocyte plasma membrane. Toxicol Appl Pharmacol 1990; 104:290-300. [PMID: 2363180 DOI: 10.1016/0041-008x(90)90303-c] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Two lines of evidence support the concept that cardiotoxin from Naja naja siamensis interacts directly with the plasma membrane to produce selective cytolysis of lymphocytes. Toxin adsorbed to the wells of microtiter plates retained the ability to lyse murine T-lymphocytes, but lost the ability to destroy natural killer cells, whereas soluble toxin obliterated both cell types. Second, toxin covalently coupled to 100-microns-diameter agarose beads, such that endocytosis would be precluded, effectively lysed L1210 tumor T-lymphocytes. Although differences were observed among susceptibilities of a variety of mouse and human tumor lymphocyte cell lines to toxin-mediated lysis, these differences were not so great as the differences between tumor and normal lymphocytes. The intrinsic selectivity of the toxin for T-lymphocytes, plus its retention of cytolytic potential when affixed to a solid support, suggests that such a protein could be applied therapeutically. In addition, based upon activity which is temperature-independent and not influenced by the absence or presence of external calcium, it appears that the toxin's mode of action may be different from that involved with erythrocyte hemolysis or with skeletal or cardiac muscle depolarization.
Collapse
Affiliation(s)
- C L Hinman
- Department of Medicinal and Biological Chemistry, University of Toledo, Ohio 43606-3390
| | | | | |
Collapse
|